BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class cancer therapies, today announced that members of the company’s management team will present at the following investor conferences: 9th Annual Evercore Healthcare Conference Presentation Date/Time: December 1, 2026, at 9:10 a.m. ET Piper Sandler 38th Annual Healthcare Conference Presentation Date/Time: December 2, 2026, at 10:30 a.m.